Idexx Laboratories | IDXX - Bruttoergebnis Vom Umsatz

Aktienkurs
574.00
Täglich Wechseln
11.00 1.95%
Monatlich
-2.11%
Jährlich
41.85%
Q2 Prognose
547.63




Bruttoergebnis Vom Umsatz Veränderung Datum
Abbott USD 6.54B 625M 2025-12
Accuray USD 41.89M 7.42M 2024-12
Align Technology USD 683.59M 44.39M 2025-12
AngioDynamics USD 44.78M 2.93M 2025-09
Dentsply International USD 443M 2M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.23B 18.7M 2025-12
Fujifilm JPY 347.51B 14.74B 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
Henry Schein USD 1.06B 37M 2025-12
Hologic USD 586.4M 2.9M 2025-12
Idexx Laboratories USD 658.11M 25.24M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
Masimo USD 247.3M 16.7M 2025-12
Neogen USD 99M 7.7M 2025-12
Orthofix International USD 153.28M 4.76M 2025-12
Phibro Animal Health USD 133.5M 12.6M 2025-12
ResMed USD 878.72M 57.9M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Steris USD 655.5M 9.6M 2025-12
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Zoetis USD 1.64B 73M 2025-12